AT&T announced today that it had appointed cardiologist Eric Topol as its Chief Medical Advisor. The company said he will “impact the design, development and delivery of AT&T’s healthcare IT solutions, connecting the healthcare ecosystem to enhance health outcomes and care delivery processes for patients and their caregivers.” … Click here to read the full post on Forbes. …
2012 In Review: Social Media In Cardiology
December 23, 2012 by 6 Comments
For a whole variety of reasons most cardiologists are not really comfortable diving into social media. For some reason they’re more comfortable remaining poolside, reading Braunwald or the latest mini JACC or Circulation than writing a blog or interacting with each other or their patients on Facebook or Twitter. Most cardiologists who do get their feet wet send out a few…
Guest Post: Another Round in the Debate on Diabetes and Statins
March 6, 2012 by 4 Comments
Another Round in the Debate on Diabetes and Statins by Roger Blumenthal Let me start by saying that I am proud to have Eric Topol as a friend and a trusted advisor over the past 20 years. His work has been an inspiration to cardiovascular health professionals for several decades. His new book, The Creative Destruction…
Eric Topol, Megamind
March 5, 2012 by 2 Comments
Ralph Waldo Emerson famously wrote that “a foolish consistency is the hobgoblin of little minds.” If this is true then Eric Topol, who earlier today wrote a New York Times editorial highly critical of statins, is Megamind. Here’s what he wrote in a 2004 editorial in the New England Journal of Medicine: Even today, only a…
Statins and Diabetes: Real Concern or Much Ado About Nothing?
March 5, 2012 by 6 Comments
Updated at 7 PM with a detailed comment at the bottom from C. Michael Minder of Johns Hopkins– In a New York Times Op-Ed piece on Monday, Eric Topol comments on last week’s announcement by the FDA that it was changing the label for statins. Topol focuses on the new warning that statins raise the risk…
Recent Comments